SAS has introduced new data and AI solutions tailored for the life sciences and health care industries. The SAS Clinical Acceleration Repository offers a secure, cloud-native platform to manage clinical research data and streamline the path to regulatory submission. This innovation aims to empower organizations to make informed decisions and accelerate the development of therapies.
In addition to the repository, SAS has launched SAS Data Maker for generating synthetic data to bridge gaps in real-world data. This tool addresses data privacy and scarcity challenges by creating statistically accurate data points without compromising sensitive information. AstraZeneca, a global biopharmaceutical company, plans to leverage SAS Data Maker to enhance decision-making in drug discovery and development.
The Financial Express 13month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
